Shares of Davis Select U.S. Equity ETF (NASDAQ:DUSA) reached a new 52-week low on Tuesday . The company traded as low as $21.84 and last traded at $22.11, with a volume of 11225 shares. The stock had previously closed at $22.43.

A number of hedge funds have recently added to or reduced their stakes in the business. D.A. Davidson & CO. raised its holdings in Davis Select U.S. Equity ETF by 8.7% during the second quarter. D.A. Davidson & CO. now owns 45,375 shares of the healthcare company’s stock worth $1,097,000 after purchasing an additional 3,635 shares in the last quarter. LPL Financial LLC raised its holdings in Davis Select U.S. Equity ETF by 8.1% during the third quarter. LPL Financial LLC now owns 87,070 shares of the healthcare company’s stock worth $2,200,000 after purchasing an additional 6,536 shares in the last quarter. BB&T Securities LLC raised its holdings in Davis Select U.S. Equity ETF by 74.6% during the second quarter. BB&T Securities LLC now owns 18,811 shares of the healthcare company’s stock worth $454,000 after purchasing an additional 8,037 shares in the last quarter. Private Advisor Group LLC acquired a new stake in Davis Select U.S. Equity ETF during the third quarter worth approximately $560,000. Finally, IFP Advisors Inc acquired a new stake in Davis Select U.S. Equity ETF during the second quarter worth approximately $537,000.

ILLEGAL ACTIVITY NOTICE: This piece of content was published by Daily Political and is the sole property of of Daily Political. If you are accessing this piece of content on another publication, it was illegally copied and reposted in violation of United States and international copyright laws. The correct version of this piece of content can be read at https://www.dailypolitical.com/2018/11/20/davis-select-u-s-equity-etf-dusa-sets-new-1-year-low-at-21-84.html.

About Davis Select U.S. Equity ETF (NASDAQ:DUSA)

DUSA Pharmaceuticals, Inc (DUSA) is a vertically integrated dermatology company. The Company is developing and marketing Levulan photodynamic therapy (Levulan PDT). The Company’s marketed products include Levulan Kerastick 20% topical solution with PDT and the BLU-U brand light source. Levulan Kerastick and BLU-U are used for the treatment of non-hyperkeratotic actinic keratoses (AKs), of the face or scalp.

Further Reading: Balanced Fund

Receive News & Ratings for Davis Select U.S. Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davis Select U.S. Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.